[Human serum albumin incompatibility: clinical and immunological investigations (author's transl)].
D000906:Antibodies / Q000032:analysis*; D004342:Drug Hypersensitivity / Q000150:complications / Q000188:drug therapy; D004344:Drug Incompatibility; D000939:Epitopes; D005076:Exanthema / Q000139:chemically induced; D005334:Fever / Q000139:chemically induced; D006801:Humans; D005779:Immunodiffusion; D011233:Precipitin Tests; D011239:Prednisolone / Q000627:therapeutic use; D012709:Serum Albumin / Q000009:adverse effects*; D012768:Shivering; D012769:Shock / Q000139:chemically induced; D012882:Skin Tests; D013610:Tachycardia / Q000139:chemically induced; D013997:Time Factors; D014461:Ultracentrifugation; D014581:Urticaria / Q000139:chemically induced
D000906:Antibodies; D000939:Epitopes; D012709:Serum Albumin; D011239:Prednisolone
Humanalbuminunverträglichkeit: Klinische und immunologische Untersuchungen